Koyfin Home > Directory > Health Care > Abeona Therapeutics > Return on Capital %

Abeona Therapeutics Return on Capital % Chart (ABEO)

Abeona Therapeutics annual/quarterly Return on Capital % from 2010 to 2020.
  • Abeona Therapeutics Return on Capital % for the quarter ending June 06, 2020 was -23.08 a -73.95% increase of 17.07 year over year
  • Abeona Therapeutics Return on Capital % for the last 12 months ending June 06, 2020 was -31.44 a -22.94% increase of 7.21 year over year
  • Abeona Therapeutics Annual Return on Capital % for 2019 was -30.07 a 20.51% decrease of -6.17 from 2018
  • Abeona Therapeutics Annual Return on Capital % for 2018 was -23.91 a 45.93% decrease of -10.98 from 2017
  • Abeona Therapeutics Annual Return on Capital % for 2017 was -12.93 a -38.44% increase of 4.97 from 2016
Other Margins & Efficiency Metrics:
  • Abeona Therapeutics EBITDA Margin for the quarter ending December 12, 2014 was $-196m a 79.05% decrease of -155m year over year
  • Abeona Therapeutics Return on Equity % for the quarter ending September 09, 2018 was -42.21 a 38.40% decrease of -16.21 year over year
View Chart On Koyfin

Quarterly ABEO Return on Capital % Data

06/2020-23.08
03/2020-23.42
12/2019-28.24
09/2019-40.15
06/2019-49.54
03/2019-36.58
12/2018-31.68
09/2018-27.18
06/2018-19.02
03/2018-15.74

Annual ABEO Return on Capital % Data

2019-30.07
2018-23.91
2017-12.93
2016-17.89
2015-31.78
201446.74
201322.15
201229.48
201149.52
201031.33